United States· US:0069-0435_0a9799ec-1a76-4b32-a123-6d29aa75b23a
Cibinqo
A abrocitinib product containing abrocitinib, registered in United States by Pfizer Laboratories Div Pfizer Inc. The same ATC class is registered in 15 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Abrocitinib is registered in 15 of 19 countries.
Countries holding a registration under ATC D11AH08 (abrocitinib), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Abrocitinib · ATC D11AH08
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of abrocitinib costs, country by country.
Normalised to the WHO defined daily dose (0.15 g), the median price runs from $0.26 in France to $122.11 in Switzerland — a ×472 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Abrocitinib · price per daily dose (0.15 g)
USD · FX 28 Sept 2026
- CH Switzerland$122.11
- FR France$0.26
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ABROCITINIB
- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Country
- United States (US)
- ATC code
- D11AH08
- ATC class
- Abrocitinib
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 5, 2026
Packs & prices · 1
- ndc110069-0435-30
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Abrocitinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCIBINQOPfizer Europe MA EEIG, Bruxelles
- FinlandCibinqoPfizer Europe MA EEIG
- FranceCIBINQO 200 mg, comprimé pelliculéPFIZER EUROPE MA EEIG (BELGIQUE)
- IrelandCibinqo 200 mg film-coated tabletsPfizer Europe MA EEIG
- BelgiumCibinqo 200 mgPfizer Europe MA
- NetherlandsCibinqo 200 mg, filmomhulde tablettenPfizer Europe MA EEIG
- NorwayCibinqoPfizer Europe MA EEIG
- PolandCibinqoPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Cibinqo
- Liechtenstein · Cibinqo
- Norway · Cibinqo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac1e8a9e-01a7-4d53-8aba-a0f9d6387f4b GET /v1/drugs/ac1e8a9e-01a7-4d53-8aba-a0f9d6387f4b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "200",
"substance": "ABROCITINIB",
"productndc": "0069-0435",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA213871",
"marketing_category": "NDA"
}See everything about abrocitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.